Related Experiment Videos
[Carbohydrate intolerance as a danger in infusion therapy]
Infusionstherapie Und Klinische Ernahrung
|June 1, 1987
Summary
Carbohydrate intolerance, including hereditary fructose intolerance, poses risks in infusion therapy. Careful patient assessment and avoiding fructose or sorbitol in unconscious patients are crucial for safe treatment.
Area of Science:
- Metabolic Disorders
- Clinical Nutrition
- Patient Safety
Context:
- Infusion therapy commonly involves carbohydrate administration.
- Certain carbohydrate intolerances can present risks during medical treatments.
- Patient history and age are critical factors in assessing carbohydrate tolerance.
Purpose:
- To highlight the risks of carbohydrate intolerance in infusion therapy.
- To emphasize the importance of routine screening for fructose intolerance.
- To provide guidance on safe carbohydrate administration in clinical settings.
Summary:
- Discusses hereditary fructose intolerance, fructose-1,6-biphosphatase deficiency, and glucose utilization issues in diabetes and post-aggression syndromes as risks in infusion therapy.
- Stresses that inquiring about fructose intolerance symptoms is essential in routine patient anamnesis.
- Advises against using fructose or sorbitol in unconscious patients or to correct hypoglycemia during infusion therapy, recommending xylitol at low doses as a safer alternative.
Impact:
- Informs clinicians about potential carbohydrate intolerance complications during infusion therapy.
- Promotes safer patient management by guiding carbohydrate selection and administration.
- Reduces the risk of adverse events related to undiagnosed carbohydrate metabolism disorders.